Cite
HARVARD Citation
Valovirta, E. et al. (n.d.). PD15 ‐ MP29‐02 effectively relieves both nasal and ocular symptoms in adolescents aged 12‐17 years: results from a meta‐analysis of 4 randomised controlled Seasonal Allergic Rhinitis (SAR) trials. Clinical and translational allergy. p. n/a. [Online].